Contrast Media Market Growth, Market Insights and Forecast to 2025Posted by rekha on November 28th, 2019 “The Contrast Media Market is expected to burgeon with a prominent growth rate over the forecast years to reach about US$ 6,428.5 Mn by 2025 owing to surge in prevalence of cancer, cardiovascular disorders, and other chronic diseases across the globe.” Precision Business Insights (PBI) in its report titled “Contrast Media Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. The contrast media market size was valued at US$ XX in 2018 and expected to reach US$ 6,428.5 Mn by 2025. Surge in the incidence of certain types of cancers such as prostate cancer, brain cancer, and breast cancer due to lifestyle changes coupled with increase in the demand for early stage diseases diagnosis are major factors boost the market over the forecast years. For instance, as per World Health Organization 2018 data, approximately 9.6 Mn deaths happened due to the cancer around the globe. Moreover, increase in R&D activities for the launch of newer contrast media agents, grow in demand for advanced diagnostic imaging techniques such as CT-scan and MRI, and favorable reimbursement policies for diagnostic procedures in developed and developing countries driving the contrast media agents market. However, high cost for the diagnostic procedures, poor healthcare infrastructure in underdeveloped countries, and side effects such as allergic reactions with the administration of contrast media are anticipated to limit the growth of global contrast media market in the near future. Contrast media market segmented on the basis of product type, modality, route of administration, disease indication, application, end user, and region. Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17188 Iodinated Contrast Media Expected to Dominate the Market Based on product type, global contrast media market segmented into Gadolinium-based contrast media, Iodinated contrast media, Barium-based contrast media, and Microbubble contrast media. Among all the products, iodinated contrast media dominated the market in 2018 and the segment is expected to hold the largest share over 2019-2025 owing to high penetration of iodinated contrast media in CT scans and X-ray procedures coupled with surge in R&D for the development and launch of newer products into market. For instance, in July 208, GE Healthcare launched Omnipaque Oral Solution, a ready-to-drink iodinated contrast medium used for CT Scan of the abdominal gastrointestinal tract in adults and children. However, a moderate growth rate observed in gadolinium-based contrast media owing stringent regulations for the use of these products in Europe. North America Accounts for Major Revenue Share for Contrast Media Market Precision Business Insights (PBI), contrast media market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among all the regions, North America dominated the market in 2018 due to increased rates of certain types of cancers in U.S. and Canada. For instance, according to National Cancer Institute 208, approximately 1,735,350 cases diagnosed with cancer in U.S. Moreover, rise in R&D for the development of newer products, well-established healthcare infrastructure, and favorable reimbursement policies are expected to boost the contrast media market in the North America region. Europe contrast media market anticipated to burgeon at prominent growth rate owing to adoption of advanced diagnostic procedures, increase in healthcare expenditure, and surge in incidence of cancer and other chronic diseases in the region. Product Approval and Launch of Advanced Technologies in Contrast Media Market In November 2019, GE Healthcare received FDA approval for Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent used with MRI in brain, spine and associated tissues in adult and pediatric patients for better visualization of blood brain barrier (BBB) and/or abnormal vascularity. Key player’s profiles in the report are o GE Healthcare, Bracco Imaging, Bayer HealthCare, Guerbet, Lantheus, Daiichi Sankyo, Unijules Life Sciences, J.B. Chemicals and Pharmaceuticals, Spago Nanomedicine, Taejoon Pharm, Jodas, and Magnus Health. Detailed Segmentation By Product Type o Barium-based Contrast Media o Iodinated Contrast Media o Gadolinium-based Contrast Media o Microbubble Contrast Media By Modality o X-Ray o CT-Scan o Magnetic Resonance Imaging (MRI) o Ultrasound o Others By Route of Administration o Oral Contrast Media o Injectable Contrast Media o Rectal Contrast Media o Urethral Contrast Media o Others By Disease Indication o Musculoskeletal Disorders o Neurological Disorders o Nephrological Disorders o Cardiovascular Disorders o Oncology o Gastrointestinal Disorders By Application o Radiology o Interventional Radiology o Interventional Cardiology By End User o Hospitals o Clinics o Diagnostic Centers o Others Geography o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/ Like it? Share it! More by this author |